Assesment of anxiety and depression in a randomized, double-blind, placebo-controlled study of galcanezumab in adults with treatment-resistant migraine: Results from the conquer study

Autor: Maizels, M., Buse, D., Jedynak, J.P., Hand, A., Ford, J.H., Detke, H.
Zdroj: In Journal of the Neurological Sciences 15 October 2019 405 Supplement:129-130
Databáze: ScienceDirect